A B S T R A C T Circulatinig antibodies that could be responsible for the suppressor thymus-derived (T)-cell dysfunction in active systemic lupus erythematosus (SLE) were investigated. Sera from 14 active and inactive SLE patients were compared with a pool of 22 normal sera. All sera were adsorbed with a pool of normal platelets to exclude antihistocompatibility leukocyte antigen antibodies; with AB erythrocytes to exclude isohemagglutinins; and with a pool of normal bone marrow-derived (B) 
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weed mitogen showed values of 17+5% and 717 + 134 ng/culture, respectively, for suppressor cells treated with the adsorbed, active SLE sera. This was significantly different from those treated with the inactive SLE sera or with the pool of normal sera. The antisuppressor-cell factor was shown to be IgG, complement independent, not cytotoxic, active at 37°C and at room temperature, but not at 4°C, and adsorbable with T cells. Suppressor T-cell antibody in sera of active SLE patients could be responsible for the observed suppressor T-cell dysfunction seen in active SLE. The mechanisms responsible for the induction of the antisuppressor-cell antibody are unknown.
INTRODUCTION
Suppressor-cell dysfunction was postulated (1) and shown (2-6) to play a key role in the expansion and hyperactivity of the autoreactive clones in systemic lupus erythematosus (SLE).' It has recently been shown by us that suppressor-cell dysfunction in active SLE is limited to the thymus-derived (T)-cell subpopulation, as shown by their failure to be activated by concanavalin A (Con A) (6) .
Lymphocytotoxic autoantibodies were shown in sera of SLE patients by several investigators (7) (8) (9) (10) . Some of them were shown to be specific for T cells (8, 9) and a T-cell subpopulation (10) . In NZB/Wnmice, which simulate human SLE in several ways, natural thymocytotoxic antibody (NTA) was detected in sera of these animals early in life, before the detection of suppressor-cell deficiency (11, 12) . The antibody was shown to have antisuppressor T-cell activity (12, 13) 'Abbreviations used in this paper: Con A, concanavalin A; NTA, natural thymocytotoxic antibody; PHA, phytohemagglutinin; PWM, pokeweed mitogen; SI, specific incorporation; SLE, systemic lupus erythematosus. and was implicated in the pathogenesis of the autoimmune state in these mice (11) (12) (13) .
In this report we have shown that the sera of active SLE patients are capable of inhibiting the in vitro suppressor potential of Con A-activated, blood mononuclear cells of normal donors. We propose that the antisuppressor-cell antibody plays a key role in the induction and(or) the maintenance of the suppressorcell dysfunction that leads to the expansion and hyperactivity of the autoreactive clones in active SLE.
METHODS
Patients. 14 patients with documented SLE were studied. Details of the main clinical and serological features of these patients have been published (6) . Patients were studied when their disease was active and again during clinical remission. Disease activity was determined by a rise in sedimentation rate, fever, and increased symptoms, together with a drop in serum complement and(or) increased serum antinative DNA antibody. The controls were 22 normal, healthy laboratory or medical personnel that were roughly age-matched to the SLE patients.
Adsorption of the various sera. (14) were incubated with the adsorbed SLE or control sera using various doses, periods, and temperatures, with or without guinea pig complement. The cells were then washed thrice in RPMI 1640 with 10% fetal calf serum (Grand Island Biological Co., Grand Island, N. Y.), incubated for 24 h with or without 20 ,tg Con A (Pharmacia Fine Chemicals, Inc., Uppsala, Sweden), washed thrice, and then cocultured with fresh, autologous, blood mononuclear cells, to which 10 ug phytohemagglutinin (PHA) or 100 ug pokeweed mitogen (PWM) was added for 3 or 7 d, respectively. The culture conditions and the evaluation of proliferative response and B-cell Ig synthesis and secretion were performed by previously described methods (2, 6, 15) .
Evaluation of the Ig nature of the antisuppressor-cell antibody. The adsorbed sera were treated with activated Sepharose 4B (Pharmacia Fine Chemicals, Inc.) columns, to which heavy chain specific anti-human IgG, IgM, or IgA antisera were bound. Depletion of the various Ig classes was confirmed by immunoelectrophoresis. The adsorbed, Ig-depleted sera were then tested for antisuppressorcell activity as outlined above.
The cytotoxicity assay was performed by the standard 1% trypan blue exclusion method (15) , and the statistical analysis was done with the Student's t test.
RESULTS
Preliminary experiments were performed to characterize the optimal conditions for inhibiting the Con A activation of normal, blood mononuclear cells. It was found that 0.1 ml of the adsorbed sera added to 1 x 106 cells for 45 min at 37°C or room temperature was optimal for the inhibition. Adding 0.1-0.5 ml guinea pig complement to the culture did not enhance the inhibitory activity of the sera, nor did it result in cell killing as detected by the dye exclusion method. Therefore, in the experiments shown in Tables 1-111, 0.1 ml of the various adsorbed sera were added to 1 x 106 normal, blood mononuclear cells suspended in 1 ml RPMI-1640 and incubated at room temperature for 45 min in the absence of complement. Table I shows that sera from the active SLE patients eliminated the suppressive effect of Con A-activated cells in the autologous PHA-stimulated cultures. This is demonstrated by a specific incorporation (SI) ratio of 67± 13 (mean-+-SD) which is not significantly different from the SI of cultures not activated by Con A (footnote, Table I ). The SI values of cultures treated with the active SLE sera were significantly different from those treated with the inactive SLE sera or with the pool from the control sera (P < 0.001). Table I also shows that there were no significant differences of the background counts of the various groups. , Table II ) and significantly different from those treated with the inactive SLE sera or with the pool from the control sera.
Depletion of IgG, but not of IgM or IgA from five active SLE sera that were tested eliminated the inhibitory effects on the Con A-activated cells (Table III) . This would indicate the IgG nature of the inhibitory factor in the active SLE sera.
Adsorption of the five active SLE sera with normal, pool T cells eliminated the inhibitory effects of the Con A-activated cells (Table III) (13) . Analysis by fluorescence-activated cell sorter revealed that mouse suppressor T cells have high NTA-reactive antigen (13) and that human regulatory T cells bind to sera from active juvenile rheumatoid arthritis patients (16, 17) . These studies, ours and those recently published by Twomey et al. describing antibody effects on Con Ainduced suppression in SLE patients, indicate that these antibodies could be responsible for the preferential loss of suppressor T cells that would lead to the various autoimmune abnormalities (16, 18, 19) . The mechanisms responsible for the production of the antisuppressor-cell antibody in active SLE are unknown. We can postulate that genetic factors combined with viral infections with specificity to receptors on the suppressor-cell subpopulation could result in transient changes in the antigenicity of these cells. This will result in a break of self-tolerance and the formation of autoantisuppressor-cell antibody, suppressor-cell loss and(or) dysfunction, and the subsequent initiation or activation of the autoimmune state.
